Structure-based design of thioether-bridged cyclic phosphopeptides binding to Grb2-SH2 domain

被引:14
作者
Li, P
Peach, ML
Zhang, MC
Liu, HP
Yang, DJ
Nicklaus, M
Roller, PP [1 ]
机构
[1] NCI, Med Chem Lab, NIH, Frederick, MD 21702 USA
[2] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.1016/S0960-894X(03)00015-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of phosphotyrosine containing cyclic peptides was designed and synthesized based upon the phage library derived cyclopeptide, G1TE. Considering the type-I beta-turn feature of peptidic ligand binding to Grb2 SH2 domain, we introduce alpha, alpha-disubstituted cyclic amino acid, Ach, into the 4th position of the cyclic peptide to induce a local right handed 3(10) helical conformation. In order to stabilize the favorable binding conformation, the bulky and hydrophobic amino acids, neopentylglycine (NPG) and phenylalanine, were introduced into the 8th and 2nd positions of the peptide ligand, respectively. To facilitate the sidechain of pTyr3 reaching into the phosphotyrosine binding pocket, a less bulky alanine was preferred in position 1. Based upon these global modifications, a highly potent peptide ligand 12 was discovered with an IC50 = 1.68 nM, evaluated by ELISA binding essay. Ligand 12 is at least 10(5) more potent than the lead peptide, termed G1TE. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:895 / 899
页数:5
相关论文
共 15 条
[1]   Structure-based design of a non-peptidic antagonist of the SH2 domain of Grb2 [J].
Caravatti, G ;
Rahuel, J ;
Gay, B ;
Furet, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) :1973-1978
[2]   Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2 [J].
Ettmayer, P ;
France, D ;
Gounarides, J ;
Jarosinski, M ;
Martin, MS ;
Rondeau, JM ;
Sabio, M ;
Topiol, S ;
Weidmann, B ;
Zurini, M ;
Bair, KW .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (06) :971-980
[3]   Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic [J].
Furet, P ;
García-Echeverria, C ;
Gay, B ;
Schoepfer, J ;
Zeller, M ;
Rahuel, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (13) :2358-2363
[4]   Structural requirements for Tyr in the consensus sequence Y-E-N of a novel nonphosphorylated inhibitor to the Grb2-SH2 domain [J].
Long, YQ ;
Yao, ZJ ;
Voigt, JH ;
Lung, FDT ;
Luo, JH ;
Burke, TR ;
King, CR ;
Yang, DJ ;
Roller, PP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (03) :902-908
[5]  
LONG YZ, UNPUB
[6]   Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain [J].
Lou, YC ;
Lung, FDT ;
Pai, MT ;
Tzeng, SR ;
Wei, SY ;
Roller, PP ;
Cheng, JW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 372 (02) :309-314
[7]   Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain [J].
Lung, FDT ;
Long, YQ ;
King, CR ;
Varady, J ;
Wu, XW ;
Wang, S ;
Roller, PP .
JOURNAL OF PEPTIDE RESEARCH, 2001, 57 (06) :447-454
[8]   THE GRB FAMILY OF SH2 DOMAIN PROTEINS [J].
MARGOLIS, B .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1994, 62 (03) :223-244
[9]   Crystal structures of the SH2 domain of Grb2: Highlight on the binding of a new high-affinity inhibitor [J].
Nioche, P ;
Liu, WQ ;
Broutin, I ;
Charbonnier, F ;
Latreille, MT ;
Vidal, M ;
Roques, B ;
Garbay, C ;
Ducruix, A .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 315 (05) :1167-1177
[10]   Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain [J].
Ogura, K ;
Tsuchiya, S ;
Terasawa, H ;
Yuzawa, S ;
Hatanaka, H ;
Mandiyan, V ;
Schlessinger, J ;
Inagaki, F .
JOURNAL OF BIOMOLECULAR NMR, 1997, 10 (03) :273-278